AAAkbar Ali

Akbar Ali

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Akbar Ali has a total of 22 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Urine drug screen co-positivity and the fentanyl testing gap among adult psychiatric emergency department encounters in West Virginia: a cross-sectional analysis

    by Dakota T. May, Akbar Ali, Christopher E. Potts, Shivam Gandhi, Robert Carter, Rajan Lamichhane, Mariam Ghafoor, Usman Alizai

    Traditional opiate immunoassays do not reliably detect fentanyl, and patterns of presumptive drug co-positivity in psychiatric emergency care remain poorly characterized. To describe class-specific urine drug screen positivity, quantify co-positivity among explicitly co-tested encounters, and assess the fentanyl testing gap among adult psychiatric emergency department encounters at two hospitals in West Virginia. We retrospectively analyzed 1,091 adult psychiatric emergency department encounters at two West Virginia hospitals from October 2020 through December 2024. Testing was clinician-directed. Class-specific estimates used only encounters tested for each class. Six-core-class co-positivity was assessed among 281 complete-panel encounters; complete and incomplete panels were compared. Multivariable logistic regression evaluated fentanyl and amphetamine/methamphetamine co-positivity among 350 co-tested encounters. Among tested encounters, tetrahydrocannabinol was positive in 214 of 513 (41.7%), amphetamine/methamphetamine in 203 of 509 (39.9%), and fentanyl in 146 of 519 (28.1%). Among complete-panel encounters, 128 of 281 (45.6%) were positive for at least two core classes. Substance-related chief complaints were more common among complete-panel encounters than among incomplete-panel encounters (73.3% versus 56.8%; p < .001). Among fentanyl-positive encounters co-tested for amphetamine/methamphetamine, 81 of 108 (75.0%) were also positive for amphetamine/methamphetamine. Amphetamine/methamphetamine positivity was associated with fentanyl positivity (adjusted odds ratio, 8.5; 95% confidence interval, 4.8-14.9). Among 118 fentanyl-positive encounters co-tested using the traditional opiate assay, 91 (77.1%) were opiate-screen-negative. Fentanyl and amphetamine/methamphetamine screens frequently overlapped in clinically selected subsets, and traditional opiate screening missed most fentanyl-positive screens. Psychiatric emergency services in fentanyl-affected regions should evaluate fentanyl-specific testing. Because immunoassays were presumptive and testing was nonprotocolized, findings represent screening yield, not confirmed exposure or population prevalence.

  • Open Access

    A Disk-Height Convention in the CAMUS Reference Implementation Lowers Computed Ejection Fraction by Approximately Eight Points

    by Akbar Ali, Christopher Potts, Shivam Gandhi, Mohamed Shelig, Davinder Singh, Zoya Z. Sayyed, Ellen Thompson

    Background and Objective. The CAMUS dataset is a widely used public benchmark for echocardiographic segmentation, and its distributed reference ejection-fraction (EF) values are frequently used as ground truth for training and evaluating automated measurement models. We examined how the dataset's reference implementation handles the disk height in Simpson's method of disks, and quantified the effect of that choice on computed EF.,Methods. All 500 patients were analyzed using the expert left-ventricular segmentations in apical two- and four-chamber views at end-diastole and end-systole. Left-ventricular volumes and EF were computed by the biplane method of disks under two conventions: the shared-height convention used by the distributed reference code (a single disk height, the maximum across all four traces, applied to both instants) and a phase-specific convention (each instant using the disk height derived from its own long axis). For every patient we recorded the phase from which the maximum height was drawn, the ratio of shared-height to phase-specific end-systolic volume, and the resulting difference in EF.,Results. The maximum disk height was drawn from an end-diastolic trace in 499 of 500 patients (99.8%). End-diastolic volume was essentially unchanged between conventions (mean difference 0.005 mL), whereas end-systolic volume was scaled under the shared-height convention by a mean factor of 1.172 ± 0.076 (maximum 1.474). The inflation factor equalled the end-diastolic to end-systolic long-axis ratio in every patient, an algebraic identity verified across the cohort. Computed EF was lowered by 7.6–8.0 percentage points relative to the phase-specific convention; mean biplane EF was 44.4% under the shared-height convention and 52.0% under the phase-specific convention across the same patients.,Conclusions. The CAMUS reference computation applies an end-diastolic disk height to end-systolic disks, systematically lowering computed ejection fraction by approximately eight points. The effect is deterministic and reproducible across all 500 patients. Investigators using the distributed reference EF as a training target or benchmark should be aware that it embeds this convention. Open code reproducing both conventions is provided.

  • Open Access

    Ovarian Fibroma with Minor Sex Cord Elements in an 81-Year-Old Woman: A Rare Entity, Diagnostic Pitfall, and Comprehensive Molecular Characterization

    by Akbar Ali, Shivam Gandhi, Christopher Potts, Nathanial Branscome, Mariam Ghafoor

    BackgroundOvarian fibroma with minor sex cord elements (MSCE) is a rare sex cord-stromal tumor, with fewer than 20 cases reported in the literature since its initial description by Young and Scully in 1983. The tumor is defined by a predominantly fibromatous or thecomatous component with scattered sex cord-like cells occupying less than 10% of the tumor area. Most reported cases occur in women aged 40–65 years. We present a case in an 81-year-old woman, representing one of the oldest reported patients with this entity.CaseAn 81-year-old woman, gravida 4 para 4, with a remote history of total hysterectomy with ovarian preservation (1969) presented with abdominal discomfort and a pelvic mass, initially misinterpreted on computed tomography (CT) as uterine in origin due to incomplete surgical history. Pelvic ultrasonography identified a 10.6 cm complex cystic mass adjacent to the vaginal cuff. Robotic-assisted bilateral salpingo-oophorectomy revealed a 9 cm right ovarian mass. Histopathology demonstrated a neoplastic spindle cell proliferation in a fibrocollagenous stroma with scattered tubules, trabeculae, and clusters of luteinized cells comprising less than 10% of the tumor. Immunohistochemistry and next-generation sequencing confirmed the diagnosis of ovarian fibroma with MSCE, with microsatellite-stable status and no reportable genetic alterations. Pelvic washings were negative for malignancy. The patient had no clinical or biochemical evidence of hormonal hypersecretion despite the presence of luteinized cells. Postoperative recovery was uneventful from a gynecologic standpoint.ConclusionThis case highlights the rarity of ovarian fibroma with MSCE in advanced age, the diagnostic challenge posed by remote pelvic surgery when surgical history is incomplete, and the value of comprehensive molecular characterization in rare ovarian tumors. The absence of hormonal manifestations despite luteinized cells underscores the variable clinical behavior of this entity.

  • Open Access

    Ovarian Fibroma With Minor Sex Cord Elements and Luteinized Cells in an 81‐Year‐Old Woman: A Case Report With Molecular Findings and Review of the Literature

    by Akbar Ali, Shivam Gandhi, Christopher Potts, Nathanial Branscome, Sheharyar Raashid, Mariam Ghafoor

    Background: Ovarian fibroma with minor sex cord elements (MSCE) is a fibroma or fibrothecoma containing scattered sex cord‐type elements that occupy less than 10% of the tumor area. First described by Young and Scully in 1983, it is not recognized as a separate entity in the current World Health Organization classification, and its behavior follows that of the underlying stromal tumor. About two dozen ovarian cases have been published, a number that probably reflects under‐reporting rather than true rarity. Reported patients range from 13 to 81 years of age. Case: An 81‐year‐old woman with a remote total hysterectomy with ovarian preservation presented with abdominal discomfort, constipation, and a pelvic mass that computed tomography initially described as uterine. Pelvic ultrasonography showed a 10.6 cm complex cystic mass adjacent to the vaginal cuff. Robotic‐assisted bilateral salpingo‐oophorectomy removed a 9 cm right ovarian mass. Histology showed a fibroma with scattered tubules, trabeculae, and nests of sex cord‐type cells and a few clusters of luteinized cells, together less than 10% of the tumor; the sex cord elements expressed SF‐1, WT1, calretinin, and inhibin. A targeted next‐generation sequencing panel performed by the consulting reference laboratory showed no reportable variants, including no FOXL2 c.402C>G mutation, and microsatellite stability. Pelvic washings were negative. She had no clinical signs of hormone excess before surgery; hot flashes reported at follow‐up were not investigated biochemically and have several possible explanations. There was no recurrence at 8 months. Conclusion: This case adds an octogenarian patient and targeted sequencing data to the limited published experience with ovarian fibroma with MSCE. Recognition of the minor sex cord component did not change management; its practical importance lies in excluding adult granulosa cell tumor, for which adequate sampling and, when needed, FOXL2 mutation analysis are useful.

  • Open Access

    Seronegative Autoimmune Encephalitis Presenting With Severe Neuropsychiatric Symptoms in an Older Adult: A Case of Diagnostic Complexity

    by Christopher E. Potts, Akbar Ali, James Issa, Usman Alizai, Dakota May

    Autoimmune encephalitis (AE) represents a potentially reversible cause of subacute cognitive and psychiatric decline. When no autoantibodies are detected, seronegative AE remains diagnostically challenging, particularly among older adults presenting with new‐onset neuropsychiatric symptoms. This report describes an older adult with recurrent episodes of confusion, aphasia, and psychosis whose diagnostic studies—including magnetic resonance imaging (MRI) and cerebrospinal fluid (CSF) analysis—were unremarkable. The individual had previously demonstrated substantial improvement after corticosteroid therapy and was again treated empirically with immunotherapy following psychiatric consultation. This case highlights the importance of maintaining a high index of suspicion for AE when standard serologic markers are absent and underscores the collaborative role of psychiatry and neurology in evaluating rapidly progressive cognitive and behavioral syndromes, which may present initially as primary psychiatric illness. Early consideration of autoimmune etiologies and prompt initiation of immunotherapy can significantly improve outcomes in patients with otherwise unexplained, rapidly progressive cognitive or behavioral syndromes.

  • Open Access

    Unraveling Protracted Neuropsychiatric Symptoms in a Patient With Altered Post‐Bariatric Pharmacokinetics: A Diagnostic Puzzle

    by Akbar Ali, Christopher E. Potts, Dakota May

    Objective: To report a complex case of serotonin toxicity that evolved into a persistent neuropsychiatric syndrome, complicating the differential diagnosis between protracted toxicity, prolonged SSRI discontinuation syndrome, acute hepatic porphyria, and functional neurological disorder (FND). Method: We present the case of a 61‐year‐old male with a history of gastric sleeve surgery and major depressive disorder (MDD) who developed acute serotonin syndrome (SS) following the concomitant use of fluoxetine, buspirone, and linezolid. Results: While acute autonomic instability resolved upon cessation of serotonergic agents, the patient developed subacute, evolving neurological deficits. Workup revealed an SLC6A4 polymorphism and elevated urinary porphyrins, initially prompting Hemin therapy, though genetic testing for porphyria was negative. Tertiary evaluation at the Cleveland Clinic ultimately confirmed a diagnosis of FND, psychogenic non‐epileptic seizures (PNES), and chronic migraine. Management remains challenging due to medication sensitivity, including recent parasomnias during a cautious trial of vilazodone. Conclusions: This case highlights the diagnostic complexity following SS in patients with altered gastrointestinal anatomy and genetic variances. It emphasizes how an acute organic insult—whether serotonin toxicity, prolonged SSRI discontinuation, or a combination of both—can serve as a physiological trigger for complex FND and PNES, requiring multidisciplinary management. The limitations inherent in single‐case observations are discussed.

  • Open Access

    Neuropsychiatric Clues to Herpes Simplex Virus Encephalitis Presenting as Normal Pressure Hydrocephalus

    by Christopher E. Potts, Alana Kassis, Akbar Ali, James Issa, Usman Alizai, Dakota May

    Herpes simplex virus type 1 (HSV‐1) encephalitis can mimic neurodegenerative or structural disorders, particularly in older adults presenting with cognitive or behavioral symptoms. We report the case of a 73‐year‐old woman with progressive gait instability, urinary incontinence, and cognitive decline, which was initially attributed to normal pressure hydrocephalus (NPH). Despite transient improvement after two lumbar punctures and neuroimaging suggestive of significant ventriculomegaly, the patient’s symptoms progressed with increasing paranoia, hallucinations, and agitation. Psychiatric consultation worked up the NPH diagnosis and identified various behavioral abnormalities—such as fluctuating delirium and psychosis—inconsistent with classic NPH. After 20 days of admission, restructuring of the differential and extensive infectious and metabolic testing led to the identification of HSV‐1 DNA in cerebrospinal fluid (CSF). The patient improved markedly with prompt acyclovir therapy. This case underscores the diagnostic overlap and mimicry between infectious and neurodegenerative processes and highlights the role of psychiatric input in reframing atypical neurocognitive presentations and expanding the differential of treatment‐resistant NPH in the presence of inconsistent symptomatic progression.